Download Contact: - Invivo Corporation

News Release Contact:
FOR IMMEDIATE RELEASE
YOUR FACITLY NAME introduces a lung screening program designed to
improve early-stage detection and reduce lung cancer mortality
DATE, CITY, STATE – Your Facility Name is proud to introduce a new lung cancer
screening program and technology designed to offer health care providers a
faster pathway to lung cancer detection and treatment.
Like all cancers, the key to lung cancer survival is early detection. In 2011, the
National Lung Screening Trial (NLST) showed that screening with low-dose
computed tomography (CT) reduced lung cancer deaths among a population
of heavy smokers by 20 percent, when compared to using chest X-rays as the
diagnostic tool.1
Your Facility Name has long been at the forefront of offering programs and
cutting-edge technology for early detection of a wide range of conditions. The
adoption of DynaLync and DynaCAD Lung from Invivo Corporation provides
critical tools to aid with the identification, tracking, and management of relevant
information to help the Your Facility Name team reach a quick, definitive
diagnosis.
XXX, Director of Radiology for Your Facility explains, “Your Facility Name is in a
unique position to be able to offer not only the advanced imaging technology
to make early lung cancer detection possible, but the data insights,
collaboration and tools that are needed to deliver the quality and consistency
required for health systems to succeed in new, evidence-based models of
patient care.”
Lung cancer is the leading cause of cancer death for both men and women
worldwide, and nearly 160,000 Americans die of lung cancer each year.2 Of the
top four deadliest cancers in the U.S. (lung, prostate, breast and colorectal), lung
cancer is the only one not subject to routine screening. Your Facility Name‘s
introduction of a lung cancer screening program could not have come at a
more opportune time.
For more information about Your Facility Name and our lung cancer screening
program, please call us at XXX or visit us on the web at XXX.
Facility Overview Information Here.
The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed
tomographic screening. N Engl J Med. 2011; 365:395-409.
2 American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society; 2015
1
- END -